Christopher E. Mahoney
Agios Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer, Lipids, and Metabolism, Nitric Oxide and Endothelin Effects, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Adrenal and Paraganglionic Tumors
Most-Cited Works
- → MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2(2009)698 cited
- → Aldosterone Inactivates the Endothelin-B Receptor via a Cysteinyl Thiol Redox Switch to Decrease Pulmonary Endothelial Nitric Oxide Levels and Modulate Pulmonary Arterial Hypertension(2012)197 cited
- → Glutathione Peroxidase-3 Deficiency Promotes Platelet-Dependent Thrombosis In Vivo(2011)184 cited
- → Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase(2019)148 cited
- → Bone Morphogenetic Protein‐2 Decreases MicroRNA‐30b and MicroRNA‐30c to Promote Vascular Smooth Muscle Cell Calcification(2012)147 cited
- → Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas(2019)92 cited
- → A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition(2019)72 cited
- → Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH(2016)68 cited
- → Glutathione peroxidase‐1 modulates lipopolysaccharideinduced adhesion molecule expression in endothelial cells by altering CD14 expression(2010)41 cited